Epidemiology of adult rheumatoid arthritis in northwest Greece 1987- 1995

Journal of Rheumatology

Volumn 24, Issue 11, 1997, Pages 2129-2133

  Drosos, Alexandros A ^a,d   Alamanos, Ioannis ^a   Voulgari, Paraskevi V ^a   Psychos, Dimitrios N ^a   Katsaraki, Aphrodite ^b   Papadopoulos, Ioannis ^a   Dimou, Georgios ^a   Siozos, Christos ^c  

^a Department of Medicine/Rheumatology ^*

^b UNIVERSITY OF IOANNINA   (Greece)

^c Hatzikosta General Hospital   (Greece)

^d UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Epidemiology; Incidence; Prevalence; Rheumatoid arthritis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ENVIRONMENTAL FACTOR; FEMALE; GREECE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ARTHRITIS, RHEUMATOID; FEMALE; GREECE; HUMANS; MALE; MIDDLE AGED; SEX FACTORS;

EID: 0030721592     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Harris ED Jr: Rheumatoid arthritis. Pathophysiology and implication for therapy. N Engl J Med 1990;322:1277-89.
2. Scott DL, Symmons DP, Coulton BL, Popert AJ: Long-term outcome of treating rheumatoid arthritis: Results after 20 years. Lancet 1990;1:1108-11.
3. Alarcón GS: Epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am 1995;21:589-604.
4. Peacock DJ, Cooper C: Epidemiology of the rheumatic diseases. Curr Opin Rheumatol 1995;7:82-6.
5. Wingrave S, Kay CR: Reduction in incidence of rheumatoid arthritis associated with oral contraceptives. Lancet 1978;1:567-71.
6. Hochberg MC: Changes in the incidence and prevalence of rheumatoid arthritis in England and Wales, 1970-1982. Semin Arthritis Rheum 1990;19:294-302.
7. Hazes JMW, Dijkmans BAC, Vanderbroucke JP, de Vries RRP, Cats A: Reduction of the risk of rheumatoid arthritis among women who take oral contraceptives. Arthritis Rheum 1990;33:173-9.
8. Linos A, Worthington JW, O'Fallon WN, Kurland LT: Case control study of rheumatoid arthritis and prior use of oral contraceptives. Lancet 1983;1:1299-300.
9. Hernàndez-Avila M, Liang MH, Willet WC, et al: Exogenous sex hormones and the risk of rheumatoid arthritis. Arthritis Rheum 1990;33:947-53.
10. Moutsopoulos HM, Giotaki H, Maddison PJ, Mavridis AC, Drosos AA, Skopouli FN: Antibodies to cellular antigens in Greek patients with autoimmune rheumatic diseases: Anti-Ro(SSA) antibody a possible marker of penicillamine-D intolerance. Ann Rheum Dis 1984;43:285-7.
11. Moutsopoulos HM, Skopouli FN, Sarras AK, et al: Anti Ro(SSA) positive rheumatoid arthritis: A clinicoserological group of patients with high incidence of D-penicillamine side effects. Ann Rheum Dis 1985;44:215-9.
12. Drosos AA, Lanchbury JS, Panayi GS, Moutsopoulos HM: Rheumatoid arthritis in Greek and British patients. A comparative clinical, radiological and serological study. Arthritis Rheum 1992;35:745-8.
13. Boki KA, Panayi GS, Vaughan RW, Drosos AA, Moutsopoulos HM, Lanchbury JS: HLA-class II sequence polymorphisms and susceptibility to rheumatoid arthritis in Greeks. The HLA-DRß shared-epitope hypothesis accounts for the disease in only a minority of Greek patients. Arthritis Rheum 1992;358:749-55.
14. Boki KA, Drosos AA, Tzioufas AG, Lanchbury JS, Panayi GS, Moutsopoulos HM: Examination of HLA-DR4 as a severity marker for rheumatoid arthritis in Greek patients. Ann Rheum Dis 1993;52:517-9.
15. Drosos AA, Moutsopoulos HM: Rheumatoid arthritis in Greece: Clinical, serological and genetic considerations. Clin Exp Rheumatol 1995;(suppl 12)13:S7-S12.
16. Arnett FC, Edworthy SM, Bloch DA, et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
17. Rumeau-Rouquette C, Breart G, Padieu R: Methodes en epidemiologie. Paris: Flammarion, 1985.
18. MacGregor AJ, Riste LK, Hazes JMW, Silman AJ: Low prevalence of rheumatoid arthritis in black Caribbeans compared with whites in inner city Manchester. Ann Rheum Dis 1994;53:293-7.
19. Linos A, Worthington JW, O'Fallon WM, Kurland LT: The epidemiology of rheumatoid arthritis in Rochester, Minnesota: A study of incidence, prevalence and mortality. Am J Epidemiol 1980;111:87-98.
20. Guillemin F, Briancon S, Klein JM, Sauleau E, Pourel J: Low incidence of rheumatoid arthritis in France. Scand J Rheumatol 1994;23:264-8.
21. O'Sullivan JB, Cathcart ES, Bolzan JA: Diagnostic criteria and the incidence of rheumatoid arthritis in Sudbury: Population studies of the rheumatic diseases. (International Congress Series). Excerpta Medica 1968;148:109-13.
22. Chan KW, Felson DT, Yood RA, Walker AM: Incidence of rheumatoid arthritis in central Massachusetts. Arthritis Rheum 1993;36:1691-6.
23. Steinbrocker O, Traeger CH, Batterman RC: Therapeutic criteria in rheumatoid arthritis. JAMA 1949;140:659-62.
24. Silman AJ, MacGregor AJ, Thompson W, et al: Twin concordance rates from rheumatoid arthritis: Results from a nationwide study. Br J Rheumatol 1993;32:903-7.
25. Moody GM, Hammond MG: Differences in HLA-DR association with rheumatoid arthritis among migrant Indian communities in South Africa. Br J Rheumatol 1994;33:425-7.
26. Stastny P: Association of the B cell alloantigen DRW4 with rheumatoid arthritis. N Engl J Med 1978;298:869-71.
27. Nepom GT, Hansen JA, Nepom BS: The molecular basis for HLA class II associations with rheumatoid arthritis. J Clin Immunol 1987;71:1-7.
28. Gregersen P, Silver J, Winchester R: The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987;30:1205-13.
29. Weyand C, Congping X, Goronzy JJ: Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis. J Clin Invest 1992;89:2033-9.
30. Weyand C, Hicok K, Conn D, Goronzy JJ: The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Intern Med 1992;117:801-6.
31. Van Zeben D, Hazes JMW, Zwinderman AH, et al: Association of HLA-DR4 with more progressive disease course in patients with rheumatoid arthritis. Arthritis Rheum 1991;34:822-30.
32. Nepom GT, Nepom BS: Prediction of susceptibility to rheumatoid arthritis by human leukocyte antigen genotyping. Rheum Dis Clin North Am 1992;18:785-92.
33. Rodna E, Pascual E, Gibson T: Differences between Spanish and British patients in the severity of rheumatoid arthritis. Comment on the article by Drosos, et al (letter). Arthritis Rheum 1994;37:147-8.
34. McDaniel O, Reveille JD, Pratt PW, Alarcón GS: Seropositivity, but not the "rheumatoid epitope" predicts disease severity in African-American RA patients (abstr). Arthritis Rheum 1994;(suppl)37:S169.
35. McDaniel O, Reveille JD, Pratt PW, Alarcón GS: The large majority of African-American patients with seropositive RA do not possess the rheumatoid epitope (abstr). Arthritis Rheum 1994;(suppl)37:S169.
36. Reveille JD, Alarcón GS, Fowler S, et al: Lack of a gene-dose effect for the rheumatoid epitope in RA patients from a large multicenter clinical study (abstr). Arthritis Rheum 1994;(suppl)37:S359.
37. Benazet JF, Reviron D, Mercier P, Roux H, Roudier J: HLA-DRB1 alleles associated with rheumatoid arthritis in Southern France. Absence of extraarticular disease despite expression of the shared epitope. J Rheumatol 1995;22:607-10.
38. Kremer JM, Lawrence DA, Jubiz W, et al: Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis: Clinical and immunologic effects. Arthritis Rheum 1990;33:810-20.
39. Linos A, Kaklamanis E, Kontomerkos A, et al: The effect of olive oil and fish consumption on rheumatoid arthritis - A case control study. Scand J Rheumatol 1991;20:419-26.
40. Ullrich SE, Alcalay J, Applegate LA, Kripke MC: Immunosuppression in phototherapy. Ciba Found Symp 1981;146:131-9.